Literature DB >> 657874

Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.

S M Singhvi, A F Heald, E C Schreiber.   

Abstract

The therapeutic activity of antibiotics depends on several factors including absorption, elimination kinetics, distribution in the body, minimal inhibitory concentrations (MIC), stability against enzymes, and plasma-protein binding. Some of these factors are interrelated, for example, the extent of protein binding of an antibiotic influences its elimination kinetics, distribution into tissues, MIC, and antibacterial activity. To evaluate the potential efficacy of an antibiotic, it is important to know the extent of its binding to plasma proteins especially since the protein-bound fraction of the antibiotic is devoid of antibacterial activity. Cephalosporins are a new class of broad-spectrum antibiotics that bind to plasma proteins in different degrees. Reported values for protein binding range from 6% for cephradine to 92% for cefazolin. The effects of protein binding of some of the commonly used cephalosporins on antibacterial activity and several pharmacokinetic parameters are discussed in this communication.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657874     DOI: 10.1159/000237771

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  12 in total

1.  Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.

Authors:  F Keller; M Maiga; H H Neumayer; H Lode; A Distler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

2.  Anomalous effect of serum on the antimicrobial activity of cefoperazone.

Authors:  S D Lang; G L Cameron; P R Mullins
Journal:  Drugs       Date:  1981       Impact factor: 9.546

3.  Influence of assay methodology on the measurement of free serum ceftriaxone concentrations.

Authors:  S J Kohlhepp; D N Gilbert; J E Leggett
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 4.  Harnessing Clinical Trial and Real-World Data Towards an Understanding of Sex Effects on Drug Pharmacokinetics, Pharmacodynamics and Efficacy.

Authors:  Joyce Oi Yan Chan; Marie Moullet; Beth Williamson; Rosalinda H Arends; Venkatesh Pilla Reddy
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

5.  Moxalactam penetration of normal and osteomyelitic bone.

Authors:  R H Fitzgerald
Journal:  Arch Orthop Trauma Surg       Date:  1983

6.  Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins.

Authors:  H Rosenkranz; D Förster
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.

Authors:  S Tanayama; K Yoshida; K Adachi; T Kondo
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Penetration of cefazolin into normal and osteomyelitic canine cortical bone.

Authors:  R C Daly; R H Fitzgerald; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 9.  A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?

Authors:  Lorena Baietto; Silvia Corcione; Giovanni Pacini; Giovanni Di Perri; Antonio D'Avolio; Francesco Giuseppe De Rosa
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

10.  PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Kidney in Pregnant Subjects and Fetus.

Authors:  Ke Xu Szeto; Maxime Le Merdy; Benjamin Dupont; Michael B Bolger; Viera Lukacova
Journal:  AAPS J       Date:  2021-06-24       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.